aTyr Pharma (LIFE) Tops Q2 EPS by 6c
aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.